Quidonomics

It isn't. Every cold email an executive ignores was real work somebody was paid to do. Every meeting that runs long because someone got past the gate without being qualified costs a CRO an afternoon of judgment. Every pitch that wastes a VP's calendar is a transaction the company didn't get paid for. The economy moves; the executive's time evaporates.

Quidonomics names what's already happening: access has a price, and it's being paid by the wrong people, in the wrong direction. Sellers pay it in hours their teams spend on a channel that stopped answering. Companies pay it through executive distraction. Decision-makers pay it through inbox fatigue and calendar fragmentation. The only party not paying is the cold-outreach platform layer, which charges sellers to send mail that doesn't work and charges companies for the meetings that do.

Then the machines arrived, and the last cost collapsed. The “personal” note is generated, the “research” is scraped, the follow-up is scheduled by software that never sleeps. A machine can fake the words. It can't fake the money it stands to lose.

The Quidonomics fix is structural, not behavioral. Asking sellers to write better emails did not work. Asking executives to be more available did not work. Filtering inboxes harder did not work. Price the access. Route the payment to the company. Let the market settle the rate. When the seller pays real money for a meeting that might get declined, only the ones with a real fit will pitch. When the company is paid for the access, the meeting becomes revenue rather than overhead. When the rate is public and the rules have teeth, the marketplace polices itself.

There is an objection to all of this, and the polite version of it is what stops people reading, so here it is stated properly. Paying for access sounds like a bribe. The answer is in where the money goes. A bribe pays the person who decides. Quid pays their employer, into an account verified as a business, never the individual, and what the seller buys is half an hour. The company is paid the same whether the answer is yes or no, which is the entire point: the meeting is for sale and the decision is not. Where a structure cannot carry that distinction, we don't take the transaction. Government roles cannot accept a paid meeting on Quid at all, and healthcare purchasing, procurement and comparable decisions are reviewed before anything runs.

This isn't a clever pricing scheme dressed up as economics. It's a small, real economy, one with rules, ratings, and refunds, built on top of B2B's most expensive resource. We think it's the right way to build it. This page is where we explain why.